Several ADHD drugs recalled

Aug 17, 2009 10:42 AM

Three drugs to treat attention deficit hyperactivity disorder were just recalled by the FDA after it was discovered that some tablets could contain too much active ingredient.

The three drugs are in 20 mg tablet form, were packaged in 100 count bottles with the lot number 311756. They are:

Dextroamphetamine Saccharate
Amphetamine Aspartate
Dextroamphetamine Sulfate and Amphetamine Sulfate

According to the manufacturer, Barr Laboratories, the tablets are oval and peach-colored, and have the numbers "b/973" stamped on one side and "2/0" on the other. The company distributed the affected lot between June 11, 2009 and June 16, 2009. Only lot 311756 is affected by this recall.

The risk of taking one of these drugs with too much active ingredient, according to Barr, includes: cardiovascular, neurologic, psychiatric and gastrointestinal reactions such as: palpitations, tachycardia, hypertension, headache, tremor, tic, dyskinesia, dizziness, blurred vision, sweating, insomnia, agitation, euphoria, mania, anxiety, restlessness, nausea, diarrhea, constipation, dry mouth, and decreased appetite.

If you have medication that matches the information above, stop taking the drug immediately and return it to your pharmacy or mail order pharmacy as soon as possible.

If you have questions about these drugs, consumers can call a helpline at Barr Laboratory at: 888-742-5578 between 8:00 a.m. and 8:00 p.m. EDT Monday through Friday.

—Lisa Gill, editor, Prescription Drugs

Take a look at the risk factors and symptoms of ADHD, and find out why ADHD drug promotions don't tell the whole story.